These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2866060)

  • 1. Thyroid stimulating immunoglobulins: measurement and clinical use.
    Ollis CA; Tomlinson S; Munro DS
    Clin Sci (Lond); 1985 Aug; 69(2):113-21. PubMed ID: 2866060
    [No Abstract]   [Full Text] [Related]  

  • 2. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983.
    Munro DS
    J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408
    [No Abstract]   [Full Text] [Related]  

  • 3. Assays of thyroid-stimulating antibody.
    McKenzie JM; Zakarija M
    Methods Enzymol; 1985; 109():677-91. PubMed ID: 2859517
    [No Abstract]   [Full Text] [Related]  

  • 4. Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.
    Vitti P; Valente WA; Ambesi-Impiombato FS; Fenzi GF; Pinchera A; Kohn LD
    J Endocrinol Invest; 1982; 5(3):179-82. PubMed ID: 6286749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological aspects of Graves' disease and importance of thyroid stimulating immunoglobulins.
    Bech K
    Acta Endocrinol Suppl (Copenh); 1983; 254():3-38. PubMed ID: 6191508
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of monoclonal antibodies raised against solubilized thyrotropin receptors in a cytochemical bioassay for thyroid stimulators.
    Ealey PA; Valente WA; Ekins RP; Kohn LD; Marshall NJ
    Endocrinology; 1985 Jan; 116(1):124-31. PubMed ID: 2856871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [LATS and other antibodies against the TSH receptor].
    Rodríguez Zapata MM
    Med Clin (Barc); 1983 Feb; 80(4):177-81. PubMed ID: 6134881
    [No Abstract]   [Full Text] [Related]  

  • 8. Thyroid-stimulating autoantibodies.
    Adams DD
    Vitam Horm; 1980; 38():119-203. PubMed ID: 6291240
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid stimulating immunoglobulin (TSI) in Graves' disease.
    Ochi Y; Inui T; Kouki T; Yamashiro K; Hachiya T; Kajita Y
    Endocr J; 1998 Dec; 45(6):701-8. PubMed ID: 10395224
    [No Abstract]   [Full Text] [Related]  

  • 10. The production of thyroid-stimulating immunoglobulin (TSI) by lymphocytes from patients with Graves' disease cultured with human thyroid subcellular fractions.
    Sugenoya A; Trokoudes K; Row VV; Volpé R
    J Endocrinol Invest; 1978 Jul; 1(3):245-51. PubMed ID: 583156
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative evaluation of cyclic AMP and iodide accumulation responses to thyroid-stimulating immunoglobulins in cultured FRTL-5 cells.
    Bidey SP; Ekins RP
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):447-58. PubMed ID: 2874907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between thyroid adenylate cyclase-stimulating and thyrotropin-binding inhibitor immunoglobulins in Graves' disease.
    Chang TC; Chen FW; Chang CC; Liaw KY
    Taiwan Yi Xue Hui Za Zhi; 1985 May; 84(5):579-85. PubMed ID: 2864384
    [No Abstract]   [Full Text] [Related]  

  • 13. The thyrotrophin receptor in guinea-pig thyroid homogenate: interaction with the long-acting thyroid stimulator.
    Manley SW; Bourke JR; Hawker RW
    J Endocrinol; 1974 Jun; 61(3):437-45. PubMed ID: 4366120
    [No Abstract]   [Full Text] [Related]  

  • 14. Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease.
    Massart C; Hody B; Mouchel L; Edan G; Nicol M
    Clin Chem; 1986 Jul; 32(7):1332-5. PubMed ID: 2872980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new method for assessing the thyrotropin binding inhibitory activity in the immunoglobulins and whole serum of patients with Graves' disease.
    Borges M; Ingbar JC; Endo K; Amir S; Uchimura H; Nagataki S; Ingbar SH
    J Clin Endocrinol Metab; 1982 Mar; 54(3):552-8. PubMed ID: 6120179
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thyrotropin-binding inhibitory immunoglobulins G in thyroid gland cells in patients with Graves-Basedow disease. Clinical studies].
    Nauman J; Faryna M; Kwiatkowska-Dutkiewicz E; Roszkowska K
    Endokrynol Pol; 1986; 37(4):143-52. PubMed ID: 2881778
    [No Abstract]   [Full Text] [Related]  

  • 20. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
    Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.